phosphopeptidomannan

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Cornet, Muriel: 1 article (09/2015)
2.	Kondori, Nahid: 1 article (09/2015)
3.	Mattsby-Baltzer, Inger: 1 article (09/2015)
4.	Pelloux, Hervé: 1 article (09/2015)
5.	Pinel, Claudine: 1 article (09/2015)
6.	Potton, Leila: 1 article (09/2015)
7.	Thiebaut-Bertrand, Anne: 1 article (09/2015)
8.	Yugueros Marcos, Javier: 1 article (09/2015)
9.	Bogdanos, Dimitrios P: 1 article (08/2012)
10.	Conrad, Karsten: 1 article (08/2012)

1.	Crohn Disease (Crohn's Disease) 03/01/1996 - "ELISA directed against phosphopeptidomannan of this strain was 64% sensitive and 77% specific for discriminating Crohn's disease versus ulcerative colitis and 71% sensitive and 89% specific for Crohn's disease versus controls. " 06/01/2007 - "Anti-Saccharomyces cerevisiae antibodies (ASCA), directed against the phosphopeptidomannan (PPM) part of the cell wall of the yeast, have been identified as an important and specific serological marker for Crohn's disease. "
2.	Ulcerative Colitis 03/01/1996 - "ELISA directed against phosphopeptidomannan of this strain was 64% sensitive and 77% specific for discriminating Crohn's disease versus ulcerative colitis and 71% sensitive and 89% specific for Crohn's disease versus controls. " 08/06/2012 - "Anti-GP2 and anti-Saccharomyces cerevisiae (ASCA) IgA and IgG were detected by ELISA employing recombinant human GP2 and phosphopeptidomannan, respectively and PAB by indirect immunofluorescence (IIF) in 271 sera, 169 with CD and 102 with ulcerative colitis (UC). "
3.	Invasive Candidiasis 09/01/2015 - "We conducted a retrospective study to evaluate the usefulness of immunoglobulin G (IgG) subclasses against Candida cell wall fragments (CW) and phosphopeptidomannan (PPM) for the diagnosis of invasive candidiasis (IC). " 09/01/2015 - "IgG1 anti-cell wall and IgG2 anti-phosphopeptidomannan antibodies in the diagnosis of invasive candidiasis and heavy Candida colonization."